China's Yingke PE closes third USD fund to back global biomedicine startups

China's Yingke PE closes third USD fund to back global biomedicine startups

Shanghai, China. Source: Ralf Leineweber/Unsplash

Yingke PE, an investment firm with nearly 50 billion yuan ($7.8 billion) in total assets, has announced the final close for its third US dollar-denominated fund, which will invest in biomedicine startups.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter